CXCL12 and COVID-19: Fibrocytes are known to migrate via CXCR4-CXCL12-mediated activity during fibrotic remodeling (89), and we found that this receptor was significantly upregulated in CD14+ monocyte populations in PPASC but not in severe COVID-19.